Video Enhancing the management of NAFLD patients with Fast and Agile Scores

Enhancing the management of NAFLD patients with Fast and Agile Scores

 · US/Pacific

About This Video

Scores FibroScan®-based - recording of Industry Session EASL ILC 2021. With 25% of NAFLD global prevalence, identifying early and accurately patients at increased risk of developing cirrhosis and liver-related complications is key. Attending this symposium will give you information on how to reach this goal using Scores FibroScan®-based: Fast, targeting patients with NASH + NAS≥4 + F≥2 and the 2 new scores for the identification of advanced fibrosis and cirrhosis in suspected NAFLD patients namely Agile 3+ and Agile 4.